NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Michael Lattanzi
New York University - New York / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 846709
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Michael Lattanzi's MOST POPULAR ARTICLES
1-)
Supercapacitor Electrodes with High-energy and power densities prepared from monolithic NiO/Ni NanocompositeQ LuAPS March Meeting Abstracts 2012, B26. 009, 20124192012
2-)
Primary melanoma histologic subtype: impact on survival and response to therapyM Lattanzi, Y Lee, D Simpson, U Moran, F Darvishian, RH Kim, ...JNCI: Journal of the National Cancer Institute 111 (2), 180-188, 2019702019
3-)
Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: a multicenter, single-arm, phase II trialSA Funt, M Lattanzi, K Whiting, H Al-Ahmadie, C Quinlan, MY Teo, ...Journal of Clinical Oncology 40 (12), 1312, 2022522022
4-)
Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in patients with high-risk melanomaA Pavlick, AB Blazquez, M Meseck, M Lattanzi, PA Ott, TU Marron, ...Cancer immunology research 8 (1), 70-80, 2020572020
5-)
The emerging role of antibody-drug conjugates in urothelial carcinomaM Lattanzi, JE RosenbergExpert review of anticancer therapy 20 (7), 551-561, 2020362020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept